Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04131816 · ClinicalTrials.gov registry record · NA
HeartHome: A Nurse-Driven, Home-Based Cardiac Rehabilitation Program
A NA study of Myocardial Infarction and Acute Coronary Syndrome, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 14
- Enrollment target
- 1
- Study location
NCT04131816: Completed NA study of Myocardial Infarction and Acute Coronary Syndrome, sponsored by University of North Carolina, Chapel Hill.
NCT04131816 is a NA study of Myocardial Infarction and Acute Coronary Syndrome that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 14 participants, below the 4,682-participant average among 64 other Myocardial Infarction trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04131816, a NA study of Myocardial Infarction and Acute Coronary Syndrome, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this implementation trial is to execute a nurse-led, home-based cardiac rehabilitation (HBCR) program, evaluate the program's impact on patient outcomes over 6 months; and compare outcomes of HeartHome (HH) participants to a group of participants in traditional cardiac rehabilitation (CR).
Primary Outcome
Number of patient referrals into the HeartHome program will be measured by the total number of participants eligible to enroll in traditional cardiac rehab that were referred to the HeartHome program.
Conditions Studied
Interventions
- BEHAVIORAL HeartHome
Study Locations (1)
North Carolina
- UNC Health Care - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2019-11-10 |
| Est. Completion | 2022-02-11 |
| Phase | NA |
What the finished NCT04131816 record still lists
NCT04131816 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 4,682-participant average among 64 other Myocardial Infarction trials with a reported enrollment target (100% lower).
The record links to 5 conditions, with Myocardial Infarction appearing as the primary indexed condition, and to 1 intervention - of which HeartHome is the first listed.
NCT04131816 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT04131816 about?
NCT04131816 is a clinical study titled "HeartHome: A Nurse-Driven, Home-Based Cardiac Rehabilitation Program". The purpose of this implementation trial is to execute a nurse-led, home-based cardiac rehabilitation (HBCR) program, evaluate the program's impact on patient outcomes over 6 months; and compare outcomes of HeartHome (HH) participants to a group of participants in traditional cardiac rehabilitation ...
What is the current status of trial NCT04131816?
This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2019-11-10. Estimated completion is 2022-02-11.
What conditions does trial NCT04131816 study?
This clinical trial studies the following conditions: Myocardial Infarction, Acute Coronary Syndrome, Angina, Stable, ST-segment Elevation Myocardial Infarction (STEMI), Non-ST-Segment Elevation Myocardial Infarction (NSTEMI).
What interventions are being tested in trial NCT04131816?
The interventions under investigation include: HeartHome (BEHAVIORAL).
Who is sponsoring clinical trial NCT04131816?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04131816 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myocardial Infarction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04131816's enrollment target sits among peer trials
14 64th of 64 higher than 1 of 64 other Myocardial Infarction trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Myocardial Infarction trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation
RECRUITING · NA
-
Women's Heart Attack Research Program: Stress Ancillary Study
RECRUITING · NA
-
Cardiac Radioablation for VT
RECRUITING · NA
-
Examination of the Impact of CalmiGo's Stress Management Device on Vascular Heath and Cardiovascular Disease Risk.
RECRUITING · NA
-
Reducing Blood Pressure in Patients With High Cardiovascular Risk
RECRUITING · NA
-
Influence of Pulse Electromagnetic Field Therapy on Myocardial Ischemia
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy